filmov
tv
Immunogenicity of AAV Vectors and Transgenes - Roland Herzog

Показать описание
Immunogenicity of AAV Vectors and Transgenes - Roland Herzog
Education Session from the American Society of Gene & Cell Therapy's 21st Annual Meeting
May 17, 2018
Education Session from the American Society of Gene & Cell Therapy's 21st Annual Meeting
May 17, 2018
Immunogenicity of AAV Vectors and Transgenes - Roland Herzog
Reducing the Immunogenicity of AAV through Engineering the Vector - George Church
Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop
Long-term Vector Genome Outcomes and Immunogenicity of AAV FVIII Gene Transfer in Hemophilia A
Federico Mingozzi: Assessing and modulating immune responses to AAV vectors in humans
1) Adeno Associated Virus (AAV) - An Introduction
The Issue: AAV Immunogenicity with Federico Mingozzi, PhD
Basics of AAV Gene Therapy
Immunogenicity of AAV-based gene therapies
Overcoming immunogenicity of gene therapies
Community Quick Takes: AAV Immune Response
HOT TOPICS | AAV Delivery
F. Mingozzi - Overcoming immune responses to AAV vectors
Immunogenic Response against Gene therapy: rAAV (recombinant Adeno-associated virus) #Code: 195
Ethical Challenges of Immunogenicity & Toxicity in Pediatric Gene Therapy Research
Biopharma 101: Analysis of Adeno-associated Viral (AAV) Vectors (SCIEX Webinar)
The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
ESGCT e-School: Immunogenicity - the challenge of our own security system
The Promise of AAV-Mediated Antibody Delivery for the Prevention and Treatment of HIV Infection
Development of adeno-associated virus (AAV5) variants capable of reducing the immunogenicity
Introduction to AAV capsid stability screening using the Uncle
Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes
Review on the use of Adeno-Associated Virus (AAV)
Masterclass LIVE: Adeno-associated virus (AAV) protein profiling and titer determination with SCIEX
Комментарии